Blog

Immuno-Oncology Interview - Patrice Hugo Central Laboratories Biomarkers Patrice Hugo, Ph.D. Immuno-Oncology Interview - Patrice Hugo
Our CSO Patrice Hugo recently sat with members of The Conference Forum at the Immuno-Oncology 360° 2019 conference, where he discussed immuno-oncology (IO) lab services. He shared the company's...
The End to End Importance of Selecting the Right Biomarker in Cancer Studies End-to-End Services Biomarkers Patrick Hurban, Ph.D. The End to End Importance of Selecting the Right Biomarker in Cancer Studies
Researchers, healthcare providers, patients, families and friends join together on World Cancer Day to reaffirm our commitment to a unified fight against a disease that affects billions of people...
Immunotherapy and PD-L1: A primer Biomarkers Companion Diagnostics Radha Krishnan Immunotherapy and PD-L1: A primer
Advances in precision medicine have led to a shift in paradigm for oncology research, from targeted therapies that rely largely on tyrosine kinase inhibitors (TKIs) to personalized therapy that can...
Immunotherapy takes center stage on World Cancer Day Clinical Trials Central Laboratories Kathleen Gray Immunotherapy takes center stage on World Cancer Day
Author: Kathleen Gray, PhDThis is an exciting time to be working in the field of cancer research. Throughout the last few years, amazing strides have been made toward the ultimate goal: to turn...